Subfoveal choroidal thickness as a predictor of treatment response to anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy
Gespeichert in:
| Veröffentlicht in: | Graefe's archive for clinical and experimental ophthalmology 2016-08, Vol.254 (8), p.1651-1652 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1652 |
|---|---|
| container_issue | 8 |
| container_start_page | 1651 |
| container_title | Graefe's archive for clinical and experimental ophthalmology |
| container_volume | 254 |
| creator | Uzun, Salih Pehlivan, Emre |
| description | |
| doi_str_mv | 10.1007/s00417-016-3368-0 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1807534063</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1807534063</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-ee2806fee6de4b4948dd491c92a6f3f7cd7944513cef4cebba39dfbc0cca65ce3</originalsourceid><addsrcrecordid>eNp1kV1r1jAUx4M43OP0A3gjAW-8iTtp0qa9lDFfYODFFHYX0uRk7ezT1CSdPJ_FL2tm5wsDIZDDye_8TuBPyAsObziAOk0AkisGvGFCNC2DR2THpaiZgurqMdmBqjhrRXV1TJ6mdAMFFzV_Qo4rxblqu25HflyuvQ-3aCZqhxDD6EqVh9F-nTElasqhS0Q32hwiDZ7miCbvcc40YlrCnJDmQM2cR3Zrkl0nEynOLuQBp7G4rmP4ngfqzS9B6UazHKgv9RKmw7It_Lt6c4TF5OHwjBx5MyV8fn-fkC_vzj-ffWAXn95_PHt7waxQVWaIVQuNR2wcyl52snVOdtx2lWm88Mo61UlZc2HRS4t9b0TnfG_BWtPUFsUJeb15lxi-rZiy3o_J4jSZGcOaNG9B1UJCIwr66gF6E9Y4l99p3kHdKKgFLxTfKBtDShG9XuK4N_GgOei75PSWnC7J6bvkNJSZl_fmtd-j-zPxO6oCVBuQytN8jfGf1f-1_gTnJKlx</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1905670531</pqid></control><display><type>article</type><title>Subfoveal choroidal thickness as a predictor of treatment response to anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Uzun, Salih ; Pehlivan, Emre</creator><creatorcontrib>Uzun, Salih ; Pehlivan, Emre</creatorcontrib><identifier>ISSN: 0721-832X</identifier><identifier>EISSN: 1435-702X</identifier><identifier>DOI: 10.1007/s00417-016-3368-0</identifier><identifier>PMID: 27117899</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Angiogenesis Inhibitors - administration & dosage ; Bevacizumab - administration & dosage ; Choroid - diagnostic imaging ; Choroid Diseases - diagnosis ; Choroid Diseases - drug therapy ; Fluorescein Angiography ; Fovea Centralis ; Fundus Oculi ; Humans ; Intravitreal Injections ; Letter to the Editor ; Medicine ; Medicine & Public Health ; Ophthalmology ; Ranibizumab - administration & dosage ; Tomography, Optical Coherence ; Treatment Outcome ; Vascular diseases ; Vascular endothelial growth factor ; Vascular Endothelial Growth Factor A - antagonists & inhibitors</subject><ispartof>Graefe's archive for clinical and experimental ophthalmology, 2016-08, Vol.254 (8), p.1651-1652</ispartof><rights>Springer-Verlag Berlin Heidelberg 2016</rights><rights>Graefe's Archive for Clinical and Experimental Ophthalmology is a copyright of Springer, 2016.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-ee2806fee6de4b4948dd491c92a6f3f7cd7944513cef4cebba39dfbc0cca65ce3</citedby><cites>FETCH-LOGICAL-c372t-ee2806fee6de4b4948dd491c92a6f3f7cd7944513cef4cebba39dfbc0cca65ce3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00417-016-3368-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00417-016-3368-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27117899$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Uzun, Salih</creatorcontrib><creatorcontrib>Pehlivan, Emre</creatorcontrib><title>Subfoveal choroidal thickness as a predictor of treatment response to anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy</title><title>Graefe's archive for clinical and experimental ophthalmology</title><addtitle>Graefes Arch Clin Exp Ophthalmol</addtitle><addtitle>Graefes Arch Clin Exp Ophthalmol</addtitle><subject>Angiogenesis Inhibitors - administration & dosage</subject><subject>Bevacizumab - administration & dosage</subject><subject>Choroid - diagnostic imaging</subject><subject>Choroid Diseases - diagnosis</subject><subject>Choroid Diseases - drug therapy</subject><subject>Fluorescein Angiography</subject><subject>Fovea Centralis</subject><subject>Fundus Oculi</subject><subject>Humans</subject><subject>Intravitreal Injections</subject><subject>Letter to the Editor</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Ophthalmology</subject><subject>Ranibizumab - administration & dosage</subject><subject>Tomography, Optical Coherence</subject><subject>Treatment Outcome</subject><subject>Vascular diseases</subject><subject>Vascular endothelial growth factor</subject><subject>Vascular Endothelial Growth Factor A - antagonists & inhibitors</subject><issn>0721-832X</issn><issn>1435-702X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kV1r1jAUx4M43OP0A3gjAW-8iTtp0qa9lDFfYODFFHYX0uRk7ezT1CSdPJ_FL2tm5wsDIZDDye_8TuBPyAsObziAOk0AkisGvGFCNC2DR2THpaiZgurqMdmBqjhrRXV1TJ6mdAMFFzV_Qo4rxblqu25HflyuvQ-3aCZqhxDD6EqVh9F-nTElasqhS0Q32hwiDZ7miCbvcc40YlrCnJDmQM2cR3Zrkl0nEynOLuQBp7G4rmP4ngfqzS9B6UazHKgv9RKmw7It_Lt6c4TF5OHwjBx5MyV8fn-fkC_vzj-ffWAXn95_PHt7waxQVWaIVQuNR2wcyl52snVOdtx2lWm88Mo61UlZc2HRS4t9b0TnfG_BWtPUFsUJeb15lxi-rZiy3o_J4jSZGcOaNG9B1UJCIwr66gF6E9Y4l99p3kHdKKgFLxTfKBtDShG9XuK4N_GgOei75PSWnC7J6bvkNJSZl_fmtd-j-zPxO6oCVBuQytN8jfGf1f-1_gTnJKlx</recordid><startdate>20160801</startdate><enddate>20160801</enddate><creator>Uzun, Salih</creator><creator>Pehlivan, Emre</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20160801</creationdate><title>Subfoveal choroidal thickness as a predictor of treatment response to anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy</title><author>Uzun, Salih ; Pehlivan, Emre</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-ee2806fee6de4b4948dd491c92a6f3f7cd7944513cef4cebba39dfbc0cca65ce3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Angiogenesis Inhibitors - administration & dosage</topic><topic>Bevacizumab - administration & dosage</topic><topic>Choroid - diagnostic imaging</topic><topic>Choroid Diseases - diagnosis</topic><topic>Choroid Diseases - drug therapy</topic><topic>Fluorescein Angiography</topic><topic>Fovea Centralis</topic><topic>Fundus Oculi</topic><topic>Humans</topic><topic>Intravitreal Injections</topic><topic>Letter to the Editor</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Ophthalmology</topic><topic>Ranibizumab - administration & dosage</topic><topic>Tomography, Optical Coherence</topic><topic>Treatment Outcome</topic><topic>Vascular diseases</topic><topic>Vascular endothelial growth factor</topic><topic>Vascular Endothelial Growth Factor A - antagonists & inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Uzun, Salih</creatorcontrib><creatorcontrib>Pehlivan, Emre</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection (Proquest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Graefe's archive for clinical and experimental ophthalmology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Uzun, Salih</au><au>Pehlivan, Emre</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Subfoveal choroidal thickness as a predictor of treatment response to anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy</atitle><jtitle>Graefe's archive for clinical and experimental ophthalmology</jtitle><stitle>Graefes Arch Clin Exp Ophthalmol</stitle><addtitle>Graefes Arch Clin Exp Ophthalmol</addtitle><date>2016-08-01</date><risdate>2016</risdate><volume>254</volume><issue>8</issue><spage>1651</spage><epage>1652</epage><pages>1651-1652</pages><issn>0721-832X</issn><eissn>1435-702X</eissn><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>27117899</pmid><doi>10.1007/s00417-016-3368-0</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0721-832X |
| ispartof | Graefe's archive for clinical and experimental ophthalmology, 2016-08, Vol.254 (8), p.1651-1652 |
| issn | 0721-832X 1435-702X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1807534063 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Angiogenesis Inhibitors - administration & dosage Bevacizumab - administration & dosage Choroid - diagnostic imaging Choroid Diseases - diagnosis Choroid Diseases - drug therapy Fluorescein Angiography Fovea Centralis Fundus Oculi Humans Intravitreal Injections Letter to the Editor Medicine Medicine & Public Health Ophthalmology Ranibizumab - administration & dosage Tomography, Optical Coherence Treatment Outcome Vascular diseases Vascular endothelial growth factor Vascular Endothelial Growth Factor A - antagonists & inhibitors |
| title | Subfoveal choroidal thickness as a predictor of treatment response to anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T10%3A48%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Subfoveal%20choroidal%20thickness%20as%20a%20predictor%20of%20treatment%20response%20to%20anti-vascular%20endothelial%20growth%20factor%20therapy%20for%20polypoidal%20choroidal%20vasculopathy&rft.jtitle=Graefe's%20archive%20for%20clinical%20and%20experimental%20ophthalmology&rft.au=Uzun,%20Salih&rft.date=2016-08-01&rft.volume=254&rft.issue=8&rft.spage=1651&rft.epage=1652&rft.pages=1651-1652&rft.issn=0721-832X&rft.eissn=1435-702X&rft_id=info:doi/10.1007/s00417-016-3368-0&rft_dat=%3Cproquest_cross%3E1807534063%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1905670531&rft_id=info:pmid/27117899&rfr_iscdi=true |